|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 23 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2009-05-08 |
4 |
B |
$19.67 |
$16,110 |
I/I |
819 |
96,712 |
2.17 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-25 |
4 |
B |
$6.00 |
$16,194 |
I/I |
2,699 |
227,915 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-16 |
4 |
S |
$15.44 |
$16,293 |
I/I |
(1,053) |
143,481 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-19 |
4 |
S |
$11.80 |
$16,463 |
I/I |
(1,395) |
1,099,197 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-02 |
4 |
B |
$2.14 |
$16,580 |
I/I |
7,701 |
3,483,553 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-17 |
4 |
S |
$14.80 |
$16,813 |
I/I |
(1,136) |
15,773 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-11 |
4 |
S |
$12.25 |
$16,958 |
I/I |
(1,384) |
494,101 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$17,288 |
I/I |
1,915 |
363,668 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$17,420 |
I/I |
583 |
227,324 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-02-09 |
4 |
B |
$16.93 |
$17,474 |
I/I |
1,022 |
106,643 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-17 |
4 |
B |
$7.80 |
$17,513 |
I/I |
2,245 |
155,230 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-06 |
4 |
B |
$14.16 |
$17,561 |
I/I |
1,240 |
117,929 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-04 |
4 |
B |
$5.58 |
$17,562 |
I/I |
3,148 |
7,756 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-20 |
4 |
B |
$17.88 |
$17,698 |
I/I |
984 |
99,136 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-22 |
4 |
B |
$27.98 |
$17,852 |
I/I |
638 |
1,411,904 |
2.17 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-01 |
4 |
S |
$11.50 |
$17,884 |
I/I |
(1,555) |
123,619 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-09 |
4 |
B |
$4.05 |
$18,152 |
I/I |
4,482 |
91,239 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-09 |
4/A |
B |
$4.05 |
$18,152 |
I/I |
4,482 |
91,780 |
2.17 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$18,212 |
I/I |
(4,706) |
120,828 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$18,292 |
I/I |
2,084 |
139,554 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-30 |
4 |
B |
$14.44 |
$18,362 |
I/I |
1,271 |
132,244 |
2.17 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-06-01 |
4 |
B |
$1.58 |
$18,446 |
I/I |
11,252 |
191,133 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-05 |
4 |
B |
$5.54 |
$18,641 |
I/I |
3,364 |
11,120 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2008-01-08 |
4 |
B |
$8.76 |
$18,853 |
I/I |
2,153 |
73,252 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-10 |
4 |
B |
$7.47 |
$18,942 |
I/I |
2,536 |
211,594 |
1.5 |
- |
|
1397 Records found
|
|
Page 23 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|